An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Francisco Partners has successfully acquired IBM's Watson Health assets, establishing a new entity called Merative, headquartered in Ann Arbor, Michigan. This acquisition aims to enhance healthcare delivery through data and analytics solutions. Merative will offer six product families focused on various healthcare sectors, leveraging significant investment from Francisco Partners and other investors like True Wind Capital and Sixth Street. Notably, seasoned CEO Gerry McCarthy will lead the new company, promising to expand its market reach.
Positive
Establishment of Merative enhances focus on data analytics in healthcare.
Experienced leadership under Gerry McCarthy, who has a robust healthcare IT background.
Significant investment backing from Francisco Partners, True Wind Capital, and Sixth Street for growth opportunities.
Diverse product offerings organized into six families, catering to various healthcare sectors.
Negative
None.
Merative will deliver industry-leading data and technology across the healthcare value chain
SAN FRANCISCO--(BUSINESS WIRE)--
Francisco Partners, a leading global investment firm that specializes in partnering with technology businesses, today announced that it has completed the acquisition of healthcare data and analytics assets that were part of IBM’s (NYSE: IBM) Watson Health business, previously announced in January.
Under the ownership of Francisco Partners, the new standalone company will be called Merative and will be headquartered in Ann Arbor, Michigan.
Merative brings together market-leading offerings that deliver value across the global healthcare ecosystem, serving clients in life sciences, provider, imaging, health plan, employer, and government health and human services sectors.
Seasoned healthcare CEO Gerry McCarthy has been tapped to lead the new organization. McCarthy has been in healthcare information technology for 30 years, most recently serving as CEO of eSolutions, a Francisco Partners portfolio company, which exited to Waystar in October 2020. Prior to eSolutions, Gerry was the President of TransUnion Healthcare and an executive at McKesson.
“Merative has market leading products, top clients and talented leadership,” said McCarthy. “With the commitment, support and deep experience of Francisco Partners, we will invest heavily in expanding the reach of these products as we continue to work with clients to improve healthcare delivery, decision making and performance.”
Paul Roma, General Manager of the Watson Health business, will be transitioning to Senior Advisor to Francisco Partners. McCarthy said, “Paul has been instrumental in driving crucial transformation of the business. His relentless focus on customers has laid a solid foundation to build on, and we thank him for his leadership.”
Merative’s products will be organized into six product families, including Health Insights; MarketScan; Clinical Development; Social Program Management and Phytel; Micromedex, and Merge Imaging solutions. Francisco Partners' investment will provide Merative with significant resources and opportunities for new investment, acquisitions, partnerships, and growth.
“Francisco Partners is excited about the opportunity to partner with the team and employees at Merative to help them achieve their mission, bringing technology and expertise to clients across healthcare through industry-leading data and analytics solutions,” said Ezra Perlman and Justin Chen of Francisco Partners. “We appreciate IBM’s work in developing this business, and our ownership will help Merative drive crucial focus in executing on organic and inorganic growth strategies.”
True Wind Capital and Sixth Street are investing in Merative. True Wind Capital is a San Francisco-based private equity firm focused on investing in leading technology companies, and the team has a long-standing track record of partnering with healthcare businesses. Sixth Street is a global investment firm that uses its long-term flexible capital, data-enabled capabilities, and One Team culture to develop themes and offer solutions to companies across all stages of growth.
Deutsche Bank served as exclusive financial advisor and Kirkland & Ellis LLP served as legal advisor to Francisco Partners.
About Francisco Partners
Francisco Partners is a leading global investment firm that specializes in partnering with technology and technology-enabled businesses. Since its launch over 20 years ago, Francisco Partners has invested in over 400 technology companies, making it one of the most active and longstanding investors in the technology industry. With more than $45 billion in assets under management, the firm invests in opportunities where its deep sectoral knowledge and operational expertise can help companies realize their full potential. For more information on Francisco Partners, please visit www.Franciscopartners.com.
About Merative
Merative is a data, analytics and technology partner for the global health industry – including providers, payers, life sciences companies and governments. With trusted technology and human expertise, the company works with clients to drive real progress. Merative helps clients orient information and insights around the people they serve to improve healthcare delivery, decision making and performance. Formerly IBM Watson Health, Merative became a new standalone company under Francisco Partners’ ownership in 2022. Learn more at www.merative.com.
What is the significance of Francisco Partners acquiring IBM's Watson Health?
The acquisition allows Francisco Partners to focus on improving healthcare delivery through enhanced data and analytics solutions under the new company, Merative.
Who is leading the newly established Merative?
Merative will be led by Gerry McCarthy, an experienced CEO in healthcare information technology.
What are the main product offerings of Merative?
Merative's products will be organized into six families, including Health Insights, MarketScan, Clinical Development, and more.
What will the investment from Francisco Partners mean for Merative?
The investment will provide Merative with significant resources for growth and development, enabling new acquisitions and partnerships.
When was the acquisition of IBM Watson Health by Francisco Partners announced?
The acquisition was announced in January 2022, with completion confirmed in June 2022.
